Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
Issues and Updates in Hereditary Angioedema- (Overland Park, KS)
The treatment of hereditary angioedema (HAE) is rapidly evolving. After many years of limited treatment options, several effective medications for HAE have been introduced into clinical practice over the past 8 years. Now, a second wave of novel therapies are poised to reach the clinic. While the impact of these treatments is not yet known, it's likely the HAE treatment paradigm will shift yet again given the broadening therapeutic options available to physicians and patients. This program will provide an updated and comprehensive overview of the HAE landscape, reviewing current and emerging therapies and evidence-based treatment recommendations. Additional discussion will be provided regarding ongoing scientific efforts to better define HAE with normal C1INH, given the clinical challenges presented by this condition.
Activity Details
Activity Name: Issues and Updates in Hereditary Angioedema- (Overland Park, KS)
Description: The treatment of hereditary angioedema (HAE) is rapidly evolving. After many years of limited treatment options, several effective medications for HAE have been introduced into clinical practice over the past 8 years. Now, a second wave of novel therapies are poised to reach the clinic. While the impact of these treatments is not yet known, it's likely the HAE treatment paradigm will shift yet again given the broadening therapeutic options available to physicians and patients. This program will provide an updated and comprehensive overview of the HAE landscape, reviewing current and emerging therapies and evidence-based treatment recommendations. Additional discussion will be provided regarding ongoing scientific efforts to better define HAE with normal C1INH, given the clinical challenges presented by this condition.
Course Objectives: After participating in this educational initiative, participants should be able to:

  • Recognize the possibility of HAE in patients who present with angioedema and integrate a diagnostic workup for angioedema that includes analysis for the various types of HAE (Type I, Type II, and normal C1INH)
  • Incorporate current, novel, and emerging treatments for HAE based on an understanding of their efficacy, safety, and guidance for use
Location Information
Meeting Location: TBD
Location City: Overland Park
Location State: KS
Location Country: US
Activity Information
Start Date: 1/10/2019
End Date: 1/10/2019
Fees: Complimentary
Meeting URL: http://registerrmei.trafficmanager.net/HAEMeetings/Series/Overview.aspx?id=3485301en&seriesid=27
Credit Information
Credit Amount: 1.5
Credit Unit: Credits
Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format: Live Activity
Accreditor/Sponsor
Sponsor Name: UC San Diego School of Medicine
Sponsor Address: 9500 Gilman Drive, MC0947
Sponsor City: La Jolla
Sponsor State: CA
Sponsor Postal Code: 92093
Sponsor Country: US
Sponsor Phone: +1-858-534-3940
Sponsor Email: ocme@ucsd.edu
Contact Information
Contact Name: Cassandra Wilson
Contact Phone: 973-713-8576
Contact Email: HAEMeetings@RMEI.com

Type:     Live Activity
0 Registered Users